Back to today’s briefing

Story perspectives

Estrogen Patch Shortage Sparks FDA Talks and Alternatives

4/17/2026

47 5 Full Breakdown

Summary

Story summary

The U.S. faces a shortage of estrogen patches for menopause symptoms.
The FDA is in talks with major manufacturers to maintain full capacity.
Physician Alexis Dunne is advising alternatives such as oral estrogen, gels, or sprays.
The shortage has worsened since the FDA lifted a warning label, triggering higher prescriptions and frustration.
Some women have resorted to trading patches with friends.

1 of 1

Story summary

The U.S. faces a shortage of estrogen patches for menopause symptoms.
The FDA is in talks with major manufacturers to maintain full capacity.
Physician Alexis Dunne is advising alternatives such as oral estrogen, gels, or sprays.
The shortage has worsened since the FDA lifted a warning label, triggering higher prescriptions and frustration.
Some women have resorted to trading patches with friends.